Image For Activity Cover
CPHM2303 - CME - CheckPath Hematopathology 2023 Quarter 3
Course Description

Quarterly release of five hematopathology cases with 1 CME question and 2 non-graded optional questions each.  

Faculty/Authors

Marianna Ruzinova, MD, PhD, FASCP
Department of Pathology and Immunology
Washington University, St. Louis, Missouri 

Brooj Abro, MD
Department of Pathology & Laboratory Medicine
Emory University Hospital 

Aaron Auerbach MD, MPH, FCAP
The Joint Pathology Center
Silver Spring, Maryland 

David M. Dorfman, MD, PhD, FASCP
Brigham and Women’s Hospital
Boston, Massachusetts 

Juehua Gao, MD, FASCP
Northwestern University Feinberg School of Medicine
Chicago, Illinois 

Chakri Gavva, MD
University of New Mexico School of Medicine
Albuquerque, New Mexico 

Yi-Shan Lee, MD, PhD
Department of Pathology and Immunology
Washington University, St. Louis, Missouri 

Stephanie P. Mathews, MD
Department of Pathology & Laboratory Medicine
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina 

Nikhil Patel, MD, FCAP, FASCP
Department of Pathology
Medical College of Georgia at Augusta University
Augusta, Georgia 

Marian Rollins-Raval, MD, MPH, FASCP
Department of Pathology
University of New Mexico
Albuquerque, New Mexico 

John J. Schmieg, MD, PhD
The Joint Pathology Center
Silver Spring, Maryland 

Imran N. Siddiqi, MD, PhD, FASCP
USC Norris Comprehensive Cancer Center
Keck School of Medicine of USC
Los Angeles, California 

Xiaohong Iris Wang, MD, PhD
Department of Pathology and Laboratory Medicine
MD Anderson Cancer Center
Houston, Texas 

Linsheng Zhang, MD, PhD, FASCP
Department of Pathology and Laboratory Medicine
Emory University School of Medicine
Atlanta, Georgia 

CME Credit: 5.0
Estimated Completion Time: 5 hour
Format: Online Educational Activity and Post Exam

Physician Competencies: Patient Care, Medical Knowledge, Practice-Based Learning and Improvement, Professionalism, Systems-Based Practice    

Eligibility for CME Credit: Max three attempts. You will have a maximum of three attempts to meet the following criteria:

  • Module ≥80% = CME/CMLE credit
  • Module <80% = No CME/CMLE credit, after a maximum of three attempts

Accreditation Statement: The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME).

Credit Designation Statement: The American Society for Clinical Pathology (ASCP) designates this journal-based CME activity for a maximum of 5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions

To claim CME credit for the exercise, do the following by October 6, 2023 ​: 

  1. Review the Technical Considerations.
  2. Click Go to Course to view an overview of the modules in this course.
  3. Click Access to begin the course.
  4. Review the Pre-Reading Assignment.
  5. Review the Educational Activity and Learning Activity.
  6. Complete and submit the Post Exam. You will have a maximum of three attempts to obtain the required score. You will be notified if you have met the credit requirements after each attempt.
  7. Submit the course Evaluation.
  8. Enter the maximum number of credits offered and click Claim CME to register credit.
Faculty Disclosures 

Technical Considerations

Release Date: 09/15/2023 
Review Date:
Expiration Date: 12/31/2025 

Course Objectives
Upon completion of this activity, you will be able to:
  • Assess diagnostic skills and differential diagnoses relevant to the study cases presented in Hematopathology.

  • Evaluate appropriate ancillary testing methodology relevant to the study cases in Hematopathology.

  • Identify areas of the practice of Hematopathology relevant to the study cases where criteria or classification may have undergone recent changes, new disease entities may have emerged, or where new developments involving pathologic workup may impact therapy.

Summary
Availability: On-Demand
Credit Offered:
5 CME Credits
Powered By